Samuel Nussbaum, MD's Bio
Samuel R. Nussbaum, MD, is a professor of clinical medicine at Washington University School of Medicine and an adjunct professor at the Washington University Olin School of Business.
He was previously executive vice president for clinical health policy and chief medical officer for Anthem, where he was the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy. He was responsible for HealthCore, Anthem’s clinical outcomes research subsidiary, and helped construct the model that has evolved into the current FDA Safety Sentinel System. He had a 20-year academic career at Massachusetts General Hospital and Harvard Medical School, where he led the Clinical Endocrine Group Practice.
He serves on the boards of the OASIS Institute, NEHI, BioCrossroads and America’s Agenda, the scientific advisory board of Medidata and the healthcare advisory board of KPMG. He is chair of the Centers for Education & Research on Therapeutics Steering Committee, is a member the U.S. Department of Health and Human Services Health Care Payment Learning and Action Network Guiding Committee, and participates in Institute of Medicine activities, including serving on the Roundtable on Value and Science-Driven Health Care.
Nussbaum received the 2004 Physician Executive Award of Excellence from the American College of Physician Executives and Modern Physician magazine, and has been recognized by Modern Healthcare as one of the “50 Most Influential Physician Executives in Healthcare.”
Nussbaum earned an undergraduate degree from New York University and an MD from Mount Sinai School of Medicine. He trained in internal medicine at Stanford University and Massachusetts General Hospital and in endocrinology and metabolism at Harvard Medical School and Massachusetts General Hospital.